Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia
Clinical trial NCT00142116 · COMPLETED
Trial details
- NCT number
- NCT00142116
- Sponsor
- Steven P. Treon, MD, PhD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-01
- Primary completion
- 2004-02-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.